Home506128 • BOM
add
Parnax Lab Ltd
Previous close
₹131.65
Day range
₹128.35 - ₹133.00
Year range
₹81.00 - ₹145.00
Market cap
1.48B INR
Avg Volume
6.79K
P/E ratio
11.81
Dividend yield
-
Primary exchange
BOM
Market news
MarketBeat
14 minutes ago
Cytokinetics (NASDAQ:CYTK) Given New $84.00 Price Target at Leerink Partners
0.41%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 629.42M | 56.51% |
Operating expense | 207.20M | 28.19% |
Net income | 27.15M | 124.32% |
Net profit margin | 4.31 | 43.19% |
Earnings per share | — | — |
EBITDA | 64.34M | 61.36% |
Effective tax rate | 16.39% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.45M | 22.03% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 901.40M | — |
Shares outstanding | 11.45M | — |
Price to book | 1.69 | — |
Return on assets | — | — |
Return on capital | 7.68% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 27.15M | 124.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1982
Website
Employees
12
